ACUTE BIPHENOTYPIC LEUKAEMIA

This adverse event was reported 93 times

These drugs are most commonly taken by patients reporting ACUTE BIPHENOTYPIC LEUKAEMIA:

# Drug Count
0 CYCLOPHOSPHAMIDE 17
1 CYCLOPHOSPHAMIDE FOR INJECTION 17
2 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 17
3 BLINATUMOMAB 16
4 PREDNISONE 14
5 ABIRATERONE 11
6 ABIRATERONE ACETATE 11
7 LENALIDOMIDE 11
8 NAPROXEN 11
9 NAPROXEN SODIUM 11
See all common drugs associated with ACUTE BIPHENOTYPIC LEUKAEMIA

ACUTE BIPHENOTYPIC LEUKAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 INTERLEUKIN-10 1 0.0028
1 BLINATUMOMAB 16 0.0015
2 PEMIGATINIB 1 0.0012
3 NELARABINE 1 0.0010
4 THIOGUANINE 1 0.0005
5 INOTUZUMAB OZOGAMICIN 1 0.0003
6 MITOXANTRONE HYDROCHLORIDE 2 0.0003
7 MELPHALAN HYDROCHLORIDE 8 0.0003
8 MICAFUNGIN SODIUM 2 0.0003
9 DEFIBROTIDE SODIUM 1 0.0003
See all drugs enriched for association with ACUTE BIPHENOTYPIC LEUKAEMIA